The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function

被引:399
作者
Brueckner, Bodo
Stresemann, Carlo
Kuner, Ruprecht
Mund, Cora
Musch, Tanja
Meister, Michael
Sueltmann, Holger
Lyko, Frank
机构
[1] Deutsch Krebsforschungszentrum, Div Epigenet, D-69120 Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Div Mol Genome Anal, D-69120 Heidelberg, Germany
[3] Univ Klinikum Heidelberg, Sekt Translat Forsch, Thoraxklin, Heidelberg, Germany
关键词
CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR GENES; HUMAN CANCER-CELLS; DNA METHYLATION; EXPRESSION; HYPOMETHYLATION; SIGNATURE; RAS;
D O I
10.1158/0008-5472.CAN-06-4074
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
MicroRNAs (miRNAs) are small noncoding RNAs that repress their target mRNAs by complementary base pairing and induction of the RNA interference pathway. It has been shown that miRNA expression can be regulated by DNA methylation and it has been suggested that altered miRNA gene methylation might contribute to human tumorigenesis. In this study, we show that the human let-7a-3 gene on chromosome 22q13.31 is associated with a CpG island. Let-7a-3 belongs to the archetypal let-7 miRNA gene family and was found to be methylated by the DNA methyltransferases DNMT1 and DNMT3B. The gene was heavily methylated in normal human tissues but hypomethylated in some lung adenocarcinomas. Let-7a-3 hypomethylation facilitated epigenetic reactivation of the gene and elevated expression of let-7a-3 in a human lung cancer cell line resulted in enhanced tumor phenotypes and oncogenic changes in transcription profiles. Our results thus identify let-7a-3 as an epigenetically regulated miRNA gene with oncogenic function and suggest that aberrant miRNA gene methylation might contribute to the human cancer epigenome.
引用
收藏
页码:1419 / 1423
页数:5
相关论文
共 20 条
[1]
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases [J].
Brueckner, B ;
Boy, RG ;
Siedlecki, P ;
Musch, T ;
Kliem, HC ;
Zielenkiewicz, P ;
Suhai, S ;
Wiessler, M ;
Lyko, F .
CANCER RESEARCH, 2005, 65 (14) :6305-6311
[2]
arrayMagic:: two-colour cDNA microarray quality control and preprocessing [J].
Buness, A ;
Huber, W ;
Steiner, K ;
Sültmann, H ;
Poustka, A .
BIOINFORMATICS, 2005, 21 (04) :554-556
[3]
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [J].
Calin, GA ;
Sevignani, C ;
Dan Dumitru, C ;
Hyslop, T ;
Noch, E ;
Yendamuri, S ;
Shimizu, M ;
Rattan, S ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :2999-3004
[4]
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J].
Calin, GA ;
Ferracin, M ;
Cimmino, A ;
Di Leva, G ;
Shimizu, M ;
Wojcik, SE ;
Iorio, MV ;
Visone, R ;
Sever, NI ;
Fabbri, M ;
Iuliano, R ;
Palumbo, T ;
Pichiorri, F ;
Roldo, C ;
Garzon, R ;
Sevignani, C ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1793-1801
[5]
DNA methylation in cancer: too much, but also too little [J].
Ehrlich, M .
ONCOGENE, 2002, 21 (35) :5400-5413
[6]
Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[7]
Relevance of DNA methylation in the management of cancer [J].
Esteller, M .
LANCET ONCOLOGY, 2003, 4 (06) :351-358
[8]
HANADA M, 1993, BLOOD, V82, P1820
[9]
Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
[10]
The fundamental role of epigenetic events in cancer [J].
Jones, PA ;
Baylin, SB .
NATURE REVIEWS GENETICS, 2002, 3 (06) :415-428